70 / 89
70
31.
van den Hoogen FH, Boerbooms AM, Swaak AJ,
Rasker JJ, van Lier HJ, van de Putte LB.
Comparison of methotrexate with placebo in the
treatment of systemic sclerosis: a 24 week
randomized double-blind trial, followed by a 24
week observational trial. Br J Rheumatol
1996;35:364-72.
32.
Pope JE, Bellamy N, Seibold JR, Baron M,
Ellman M, Carette S, et al. A randomized,
controlled trial of methotrexate versus placebo
in early diffuse scleroderma. Arthritis Rheum
2001;44:1351-8.
33.
Clements PJ, Furst DE, Wong WK, Mayes M,
White B, Wigley F, et al. High-dose versus low-
dose D-penicillamine in early diffuse systemic
sclerosis: analysis of a two-year, double-blind,
randomized, controlled clinical trial. Arthritis
Rheum 1999;42:1194-203.
34.
Seibold JR, Korn JH, Simms R, Clements PJ,
Moreland LW, Mayes MD, et al. Recombinant
human relaxin in the treatment of scleroderma.
A randomized, double-blind, placebo-controlled
trial. Ann Intern Med 2000;132:871-9.
35.
Khanna D, Clements PJ, Furst DE, Korn JH,
Ellman M, Rothfield N, et al. Recombinant
human relaxin in the treatment of systemic
sclerosis with diffuse cutaneous involvement: a
randomized, double-blind, placebo-controlled
trial. Arthritis Rheum 2009;60:1102-11.
36.
Postlethwaite AE, Wong WK, Clements P,
Chatterjee S, Fessler BJ, Kang AH, et al. A